Crown Equity Holdings, Inc. financial data

Symbol
CRWE on OTC
Location
11226 Pentland Downs St., Las Vegas, NV
State of incorporation
Nevada
Fiscal year end
December 31
Former names
MICRO BIO-MEDICAL WASTE SYSTEMS, INC. (to 11/26/2007), 20/20 NETWORKS INC (to 5/23/2006), 20/20 WEB DESIGN INC (to 2/10/2003)
Latest financial report
10-Q - Q2 2024 - Aug 21, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 0.54 % +49.2%
Debt-to-equity -100 % +6.31%
Return On Equity 561 % +2793%
Return On Assets -102K % -2751%
Operating Margin -448K % -288%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 15.8M shares +18.2%
Common Stock, Shares, Outstanding 15.8M shares +18.2%
Entity Public Float 1.28M USD -68.4%
Common Stock, Value, Issued 15.8K USD +18.1%
Weighted Average Number of Shares Outstanding, Basic 15.8M shares +18.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 574 USD +152%
Research and Development Expense 0 USD
General and Administrative Expense 2.04M USD +692%
Operating Income (Loss) -2.57M USD -877%
Nonoperating Income (Expense) -2.39M USD -56125%
Net Income (Loss) Attributable to Parent -4.96M USD -1755%
Earnings Per Share, Basic -0.2 USD/shares
Earnings Per Share, Diluted -0.2 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.62K USD +131%
Assets, Current 2.36K USD -25.3%
Property, Plant and Equipment, Net 0 USD -100%
Assets 2.36K USD -35.8%
Liabilities, Current 323K USD -77.3%
Liabilities 323K USD -77.3%
Common Stocks, Including Additional Paid in Capital 13.4K USD +0.08%
Retained Earnings (Accumulated Deficit) -18.1M USD -27.7%
Stockholders' Equity Attributable to Parent -320K USD +77.4%
Liabilities and Equity 2.36K USD -35.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -21.9K USD +16.2%
Net Cash Provided by (Used in) Financing Activities 23K USD -24.5%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 450M shares 0%
Common Stock, Shares, Issued 15.8M shares +18.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -817 USD -162%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.69K USD -46.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 1.58M USD +72.7%
Depreciation 0 USD -100%
Deferred Tax Assets, Operating Loss Carryforwards 1.58M USD +72.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Additional Paid in Capital 18.3M USD +43.3%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Interest Expense 18K USD +323%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%